血液透析患者严重肢体缺血血运重建后临床成功的预后评分
本研究回顾性分析2004至2012年131例血液透析合并严重肢体缺血患者的180条患肢,构建基于年龄、冠心病和Texas大学创面分类D期的预后评分,用于预测血运重建后无截肢且无再干预生存,评分的区分度为75.5%,最佳截断值2.07。
要点
- 血液透析患者严重肢体缺血血运重建后临床成功仍较差,1年仅30.8%。
- 年龄、冠心病、TUWC D期是临床成功的独立负性因素。
- 预后评分区分度75.5%,低分者1年临床成功51.6%,高分者23.3%。
核心结论
- 血液透析患者严重肢体缺血血运重建后临床成功仍较差,与血运重建方式无关。
- 基于年龄、冠心病史和TUWC D期的预后模型可估计个体临床成功概率,可能有助于决策。
研究设计与样本
- 回顾性研究,纳入2004年1月至2012年12月连续血液透析合并严重肢体缺血患者131例,共180条患肢。
- 评估人口学、合并症、Rutherford分级、Texas大学创面分类和血运重建方式。
- 终点为血运重建后临床成功(无截肢且无再干预生存),并基于多因素分析构建预后评分。
主要发现
- 163条患肢(90.6%,117例患者)接受了血运重建:腔内52.8%、外科28.9%、杂交10.6%。
- 平均随访20.8±21.1个月,血运重建患者6、12、24个月临床成功分别为47.9%、30.8%、17.8%。
- 多因素分析显示年龄(HR 1.03,95%CI 1.01-1.05,P=.005)、冠心病(HR 1.55,95%CI 1.04-2.32,P=.032)、TUWC D期(HR 1.80,95%CI 1.22-2.67,P=.003)为独立负性因素。
- 血运重建方式对临床成功无影响。
- 评分区分度75.5%(P=.036),最佳截断值2.07;低分(<2.07)31例(26.5%),高分(>2.07)86例(73.5%)。
关键数值与推荐
- 预后评分=0.026×年龄(岁)+0.441×冠心病+0.59×TUWC D期;冠心病和TUWC D期存在为1,不存在为0。
- 评分<2.07为低风险,>2.07为高风险。
临床怎么用
- 可用于血液透析合并严重肢体缺血患者血运重建前的风险分层,辅助医患决策。
- 评分>2.07提示临床成功概率低,需谨慎评估血运重建获益。
局限性
- 回顾性研究,样本量有限(131例患者,180条患肢)。
- 单中心数据,评分需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The revascularization of critical limb ischemia (CLI) in hemodialysis (HD) patients features poor results in terms of patient survival and limb salvage. Recent predictive models in CLI revascularization did not specifically address HD patients. The aim of this study was to define risk factors for clinical success (CS) after revascularization of CLI in HD patients and to transform findings in a prognostic score. METHODS: A retrospective study was conducted of prospectively gathered data, including consecutive HD patients treated for CLI from January 2004 to December 2012. Patients' demographics, comorbidities, CLI stage (Rutherford classification), tissue loss (Texas University Wound classification [TUWC]), and type of revascularization were assessed. End points were CS after revascularization (amputation-free and reintervention-free survival) and a prognostic score for CS based on significant risk factors (multivariable analysis). RESULTS: In the study period, 131 patients (mean age, 70.2 ± 9.9 years; male, 76.3%) with a total of 180 limbs were treated. Endovascular (52.8%), surgical (28.9%), or hybrid (10.6%) revascularization was performed in 163 (90.6%) limbs in 117 patients. The mean (± standard deviation) follow-up was 20.8 ± 21.1 months. Considering revascularized patients, CS was 47.9%, 30.8%, and 17.8% at 6, 12, and 24 months, respectively. On multivariable analysis, age (hazard ratio [HR], 1.03; 95% confidence interval [CI], 1.01-1.05; P = .005), coronary artery disease (CAD; HR, 1.55; 95% CI, 1.04-2.32; P = .032), and TUWC stage D (HR, 1.80; 95% CI, 1.22-2.67; P = .003) were independent negative factors. Type of revascularization had no influence on CS. The score for predicting CS was 0.026 × age (years) + 0.441 × CAD + 0.59 × TUWC stage D. CAD and TUWC stage D were 1 in the presence of disease and 0 in the absence of disease. The score has a significant discrimination power of 75.5% (P = .036), with a best cutoff value of 2.07. Patients with a CS score <2.07 would have a low risk of clinical failure, whereas patients with a CS score >2.07 would have a high risk. There were 31 (26.5%) cases of low-risk score and 86 (73.5%) cases of high-risk score. Cases with low-risk score had a CS at 1 year of 51.6% compared with 23.3% in cases with high-risk score. CONCLUSIONS: CS after revascularization in HD patients remains poor independent of the type of revascularization. A prognostic model based on age, history of CAD, and severity of CLI (TUWC stage D lesion) can estimate an individual's chances of CS and may help in the decision-making process.
引用
- Abualhin M, Gargiulo M, Bianchini Massoni C, et al. A prognostic score for clinical success after revascularization of critical limb ischemia in hemodialysis patients. J Vasc Surg. 2019. PMID: 30922745. doi:10.1016/j.jvs.2018.11.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。